Imago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

06.09.2022 - SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering and developing new medicines for the treatment of myeloproliferative neoplasms ...

Related Keywords

California ,United States ,South San Francisco ,Laurence Watts ,Linkedin ,Gilmartin Group ,European Medicines Agency ,Facebook ,Canale Communications ,Investor Relations ,Fast Track Designation ,Orphan Designation ,